Next Article in Journal
Cyclodipeptides: From Their Green Synthesis to Anti-Age Activity
Next Article in Special Issue
Non-Criteria Obstetric Antiphospholipid Syndrome: How Different Is from Sidney Criteria? A Single-Center Study
Previous Article in Journal
Immunomodulation by Hemoadsorption—Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock: A Prospective Study
Peer-Review Record

Antiphospholipid Antibody Syndrome-Associated Increased Surface Expression of VLA4 Integrin on Human Monocytes

Biomedicines 2022, 10(10), 2341;
by Ula Štok 1,2, Neža Štucin 1,2, Elizabeta Blokar 1,3, Aleš Ambrožič 1,3, Snežna Sodin-Šemrl 1,4, Saša Čučnik 1,2,* and Polona Žigon 1,4,*
Reviewer 1:
Reviewer 2:
Biomedicines 2022, 10(10), 2341;
Submission received: 25 August 2022 / Revised: 9 September 2022 / Accepted: 13 September 2022 / Published: 20 September 2022
(This article belongs to the Special Issue Basic and Clinical Researches of Antiphospholipid Syndrome)

Round 1

Reviewer 1 Report

Please refer to the attached document.

Comments for author File: Comments.pdf

Author Response

Dear reviewer, 

thank you for your comments. Please find our report attached below. 


Author Response File: Author Response.pdf

Reviewer 2 Report

Dear Authors, the paper is well written. The authors show that VLA4 was significantly increased on the surface of monocytes from 25 APS patients. This novelty could lead to new insight of Antiphospholipid syndrome.

Author Response

Dear reviewer, thank you for your comments!


Back to TopTop